Company Farmako Srl with Fiscal Code 3963196
recorded a turnover of 2024 of
219.917,
with a net profit of
-25.501
and having an average number of employees of
4.
The company operates in the field of Comerţ cu amănuntul al produselor farmaceutice having the NACE code 4773.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
Farmako Srl
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
195.098
204.077
232.395
252.124
160.109
152.782
159.321
184.767
213.292
219.917
Total Income - EUR
195.938
204.489
237.263
254.359
411.425
153.014
159.708
184.790
213.376
219.991
Total Expenses - EUR
190.293
209.657
229.577
246.643
196.886
169.988
169.859
187.653
207.271
244.899
Gross Profit/Loss - EUR
5.645
-5.169
7.685
7.716
214.539
-16.974
-10.151
-2.864
6.105
-24.908
Net Profit/Loss - EUR
4.464
-5.664
5.511
5.173
210.424
-18.398
-11.749
-4.740
3.957
-25.501
Employees
4
4
5
5
5
4
4
4
4
4
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
In the last year of activity, the sales increased by 3.7%, from 213.292 euro in the year 2023, to 219.917 euro in 2024.
The Net Profit decreased by -3.935 euro, from 3.957 euro in 2023, to 0 in the last year.
Check the financial reports for the company - Farmako Srl
Financial Rating - FARMAKO SRL
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - Farmako Srl
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - Farmako Srl
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - Farmako Srl
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
58.305 euro in 2024 which includes Inventories of
40.247 euro, Receivables of
15.645 euro and cash availability of
2.413 euro.
The company's Equity was valued at
-28.058 euro, while total Liabilities amounted to
88.975 euro.
Equity decreased by -25.502 euro, from -2.571 euro in 2023, to -28.058 in 2024.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Farmako Srl